MSDF interviews Luke Lairson PhD of The Scripps Research Institute and the California Institute for Biomedical Research about a drug screen to find potential remyelination compounds and the strategy for researching their potential usefulness as candidate drugs to repair tissue damage in MS.
MS Discovery
Links to articles and other resources mentioned in Episode 51
A conference in Cambridge, Massachusetts, outlined progress and challenges in turning computational modeling into actionable knowledge in MS and other brain disorders
Allison Provost, Ph.D.
I’d like to tell you about a conference that Orion Bionetworks hosted at the...
Clinical Research, Drug Development, Laboratory Research, Meetings, Methods